Aspen to pay NHS £8m after CMS probe
The offer hopes to resolve competition concerns over the supply of a fludrocortisone acetate 0.1 mg tablets.
Read More
Tag: ant competitive
- NHS to offer fezolinetant for menopause‑related hot flushes and night‑sweats
- UCB reports superiority of bimekizumab in psoriatic arthritis study
- Kainova reports positive results for DT‑9081 in advanced solid tumours
- EnteroBiotix completes enrolment for trial of EBX‑102‑02
- Lundbeck completes patient randomisation early in global MSA trial
